메뉴 건너뛰기




Volumn 8, Issue 5, 1997, Pages 423-427

Adrenocortical carcinoma

Author keywords

Adrenocortical carcinoma; Chemotherapy; Genetic abnormalities; Mitotane

Indexed keywords

ADENYLATE CYCLASE; AMINOGLUTETHIMIDE; ARGININE; CISPLATIN; CORTICOTROPIN; CYCLINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FLUDROCORTISONE; FLUOROURACIL; HYDROCORTISONE; KETOCONAZOLE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METYRAPONE; MIFEPRISTONE; MITOTANE; PROTEIN P53; SOMATOMEDIN B; SURAMIN;

EID: 0030859209     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008257530919     Document Type: Review
Times cited : (24)

References (57)
  • 1
    • 0025202883 scopus 로고
    • Hormonal evaluation of the patient with an incidentally discovered adrenal mass
    • Ross N, Aron D. Hormonal evaluation of the patient with an incidentally discovered adrenal mass. N Engl J Med 1990; 323: 1401-5.
    • (1990) N Engl J Med , vol.323 , pp. 1401-1405
    • Ross, N.1    Aron, D.2
  • 2
    • 0025248241 scopus 로고
    • Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy
    • Luton JP, Cerdas S, Billaud L et al. Clinical features of adrenocortical carcinoma, prognostic factors and the effect of mitotane therapy. N Engl J Med 1990; 322: 1195-1202.
    • (1990) N Engl J Med , vol.322 , pp. 1195-1202
    • Luton, J.P.1    Cerdas, S.2    Billaud, L.3
  • 3
    • 0024370998 scopus 로고
    • Adrenal cortical carcinoma
    • Venkatesh S. Hickey R, Sellin R et al. Adrenal cortical carcinoma. Cancer 1989; 64: 765-9.
    • (1989) Cancer , vol.64 , pp. 765-769
    • Venkatesh, S.1    Hickey, R.2    Sellin, R.3
  • 4
    • 0027273847 scopus 로고
    • Adrenocortical carcinoma in children: Clinical aspects and prognosis
    • Sabagga C. Avilla S, Schulz C et al. Adrenocortical carcinoma in children: Clinical aspects and prognosis. J Pediatr Surg 1993; 28: 841-3.
    • (1993) J Pediatr Surg , vol.28 , pp. 841-843
    • Sabagga, C.1    Avilla, S.2    Schulz, C.3
  • 5
    • 16144366677 scopus 로고    scopus 로고
    • Corticosurénalomes de l'enfant: Analyse rétrospective de 54 cas
    • Teinturier C, Brugières L, Lemerle J et al. Corticosurénalomes de l'enfant: Analyse rétrospective de 54 cas. Arch Pédiatrie 1996; 3: 235-40.
    • (1996) Arch Pédiatrie , vol.3 , pp. 235-240
    • Teinturier, C.1    Brugières, L.2    Lemerle, J.3
  • 6
    • 0018835921 scopus 로고
    • Complete and incomplete forms of Beckwith-Wiedemann syndrome: Their oncogenic potential
    • Sotelo-Avila C, Gonzalez-Crussi F, Fowler J. Complete and incomplete forms of Beckwith-Wiedemann syndrome: Their oncogenic potential. J Pediatr 1980; 96: 47-50.
    • (1980) J Pediatr , vol.96 , pp. 47-50
    • Sotelo-Avila, C.1    Gonzalez-Crussi, F.2    Fowler, J.3
  • 7
    • 0025633582 scopus 로고
    • Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
    • Malkin D, Li F, Strong L et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990; 250: 1233-8.
    • (1990) Science , vol.250 , pp. 1233-1238
    • Malkin, D.1    Li, F.2    Strong, L.3
  • 8
    • 0025897503 scopus 로고
    • Recurrent or metasuitic disease in selected patients with adrenocortical carcinoma
    • Jensen J, Pass H, Sindelar W, Norton J. Recurrent or metasuitic disease in selected patients with adrenocortical carcinoma. Arch Surg 1991; 126:457-61.
    • (1991) Arch Surg , vol.126 , pp. 457-461
    • Jensen, J.1    Pass, H.2    Sindelar, W.3    Norton, J.4
  • 9
    • 0027374133 scopus 로고
    • Immunohistochemical study of adrenocortical carcinoma: Predictive value of the D11 monoclonal antibody
    • Tartour E, Caillou B, Tenenbaum F et al. Immunohistochemical study of adrenocortical carcinoma: Predictive value of the D11 monoclonal antibody. Cancer 1993; 72: 3296-303.
    • (1993) Cancer , vol.72 , pp. 3296-3303
    • Tartour, E.1    Caillou, B.2    Tenenbaum, F.3
  • 10
    • 0021350092 scopus 로고
    • Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors
    • Weiss L. Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors. Am J Surg Pathol 1984; 8: 163-9.
    • (1984) Am J Surg Pathol , vol.8 , pp. 163-169
    • Weiss, L.1
  • 11
    • 0024513504 scopus 로고
    • Pathologic features of prognostic significance in adrenocortical carcinomas
    • Weiss L, Medeiros J, Vickey A. Pathologic features of prognostic significance in adrenocortical carcinomas. Am J Surg Pathol 1989; 13: 202-6.
    • (1989) Am J Surg Pathol , vol.13 , pp. 202-206
    • Weiss, L.1    Medeiros, J.2    Vickey, A.3
  • 12
    • 0027455046 scopus 로고
    • Hypo-aldosteronism accompanied by normal or elevated mineralocorticosteroid pathway steroid: A marker of adrenal carcinoma
    • Aupetit-Faisant B, Battaglia C. Emeric-Blanchouin N, Legrand J. Hypo-aldosteronism accompanied by normal or elevated mineralocorticosteroid pathway steroid: A marker of adrenal carcinoma. J Clin Endocrinol Metab 1993; 76: 38-43.
    • (1993) J Clin Endocrinol Metab , vol.76 , pp. 38-43
    • Aupetit-Faisant, B.1    Battaglia, C.2    Emeric-Blanchouin, N.3    Legrand, J.4
  • 13
    • 0029145949 scopus 로고
    • Plasma levels of aldosterone versus aldosterone precursors: A french retrospective multicentric study
    • Aupetit-Faisant B, Blanchouin-Emeric N, Tenenbaum F et al. Plasma levels of aldosterone versus aldosterone precursors: A french retrospective multicentric study. J Clin Endocrinol Metab 1995; 80: 2715-21.
    • (1995) J Clin Endocrinol Metab , vol.80 , pp. 2715-2721
    • Aupetit-Faisant, B.1    Blanchouin-Emeric, N.2    Tenenbaum, F.3
  • 14
    • 0029838924 scopus 로고    scopus 로고
    • MHC class II expression. A new tool to assess dignity in adrenocortical tumours
    • Marx C. Wolkersdörfer G et al. MHC class II expression. A new tool to assess dignity in adrenocortical tumours. J Clin Endocrinol Metab 1996; 81: 4488-91.
    • (1996) J Clin Endocrinol Metab , vol.81 , pp. 4488-4491
    • Marx, C.1    Wolkersdörfer, G.2
  • 15
    • 0025127424 scopus 로고
    • Two G protein oncogenes in human endocrine tumors
    • Lyons J, Landis C, Harsh G et al. Two G protein oncogenes in human endocrine tumors. Science 1990; 249: 655-9.
    • (1990) Science , vol.249 , pp. 655-659
    • Lyons, J.1    Landis, C.2    Harsh, G.3
  • 16
    • 0027368204 scopus 로고
    • No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms
    • Reincke M, Karl M, Travis W, Chrousos G. No evidence for oncogenic mutations in guanine nucleotide-binding proteins of human adrenocortical neoplasms. J Clin Endocrinol Metab 1993; 77: 1419-22.
    • (1993) J Clin Endocrinol Metab , vol.77 , pp. 1419-1422
    • Reincke, M.1    Karl, M.2    Travis, W.3    Chrousos, G.4
  • 17
    • 0028983355 scopus 로고
    • Oncogenic mutations of a Gi2 protein are not determinant for human adrenocortical tumourigenesis
    • Gicquel C, Dib A, Bertagna X et al. Oncogenic mutations of a Gi2 protein are not determinant for human adrenocortical tumourigenesis. Eur J Endocrinol 1995; 133: 166-72.
    • (1995) Eur J Endocrinol , vol.133 , pp. 166-172
    • Gicquel, C.1    Dib, A.2    Bertagna, X.3
  • 18
    • 0027322205 scopus 로고
    • Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas
    • Moul J, Bishoff J, Theune S, Chang E. Absent ras gene mutations in human adrenal cortical neoplasms and pheochromocytomas. J Urol 1993; 149: 1389-94.
    • (1993) J Urol , vol.149 , pp. 1389-1394
    • Moul, J.1    Bishoff, J.2    Theune, S.3    Chang, E.4
  • 19
    • 0027981498 scopus 로고
    • Point mutations of RAS genes in human adrenocortical tumors. Absence in adrenocortical hyperplasia
    • Yashiro T, Hara H, Fulton N et al. Point mutations of RAS genes in human adrenocortical tumors. Absence in adrenocortical hyperplasia. World J Surg 1994; 18: 455-61.
    • (1994) World J Surg , vol.18 , pp. 455-461
    • Yashiro, T.1    Hara, H.2    Fulton, N.3
  • 20
    • 0024558302 scopus 로고
    • Genetic changes in human adrenocortical carcinomas
    • Yano T, Linehan M, Anglard P et al. Genetic changes in human adrenocortical carcinomas. J Natl Cancer Inst 1989; 81: 518-23.
    • (1989) J Natl Cancer Inst , vol.81 , pp. 518-523
    • Yano, T.1    Linehan, M.2    Anglard, P.3
  • 21
    • 0029115129 scopus 로고
    • Recent advances in the pathogenesis of adrenocortical tumours
    • Gicquel C, Bertagna X, Le Bouc Y. Recent advances in the pathogenesis of adrenocortical tumours. Eur J Endocrinol 1995; 133: 133-44.
    • (1995) Eur J Endocrinol , vol.133 , pp. 133-144
    • Gicquel, C.1    Bertagna, X.2    Le Bouc, Y.3
  • 22
    • 0028177520 scopus 로고
    • p53 mutations in human adrenocortical neoplasms: Immunohistochemical and molecular studies
    • Reincke M, Karl M, Travis W et al. p53 mutations in human adrenocortical neoplasms: Immunohistochemical and molecular studies. J Clin Endocrinol Metab 1994; 78: 790-4.
    • (1994) J Clin Endocrinol Metab , vol.78 , pp. 790-794
    • Reincke, M.1    Karl, M.2    Travis, W.3
  • 23
    • 0028144321 scopus 로고
    • Mutations of the p53 gene in human functional adrenal neoplasms
    • Lin S, Lee Y, Tsai J. Mutations of the p53 gene in human functional adrenal neoplasms. J Clin Endocrinol Metab 1994; 78: 483-91.
    • (1994) J Clin Endocrinol Metab , vol.78 , pp. 483-491
    • Lin, S.1    Lee, Y.2    Tsai, J.3
  • 24
    • 0029014425 scopus 로고
    • p53 activates expression of HlC-1, a new candidate tumour suppressor gene on 17p13.3
    • Makos Wales M, Biel M, El Deiry W et al. p53 activates expression of HlC-1, a new candidate tumour suppressor gene on 17p13.3. Nature Med 1995; 1: 570-7.
    • (1995) Nature Med , vol.1 , pp. 570-577
    • Makos Wales, M.1    Biel, M.2    El Deiry, W.3
  • 25
    • 0027536679 scopus 로고
    • The expression of the H-19 and IGF-2 genes during human embryogenesis and placental development
    • Goshen R, Rachmilewitz J, Schneider T et al. The expression of the H-19 and IGF-2 genes during human embryogenesis and placental development. Mol Reprod Dev 1993; 34: 374-9.
    • (1993) Mol Reprod Dev , vol.34 , pp. 374-379
    • Goshen, R.1    Rachmilewitz, J.2    Schneider, T.3
  • 26
    • 0028326318 scopus 로고
    • Parallel regulation of parentally imprinted H19 and insulin-like growth factor II genes in cultured human fetal adrenal cells
    • Voutilainen R, Ilvesmäki V. Ariel I et al. Parallel regulation of parentally imprinted H19 and insulin-like growth factor II genes in cultured human fetal adrenal cells. J Clin Endocrinol Metab 1994; 134: 2051-6.
    • (1994) J Clin Endocrinol Metab , vol.134 , pp. 2051-2056
    • Voutilainen, R.1    Ilvesmäki, V.2    Ariel, I.3
  • 27
    • 0027370355 scopus 로고
    • Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: High IGF-II expression in functional adrenocortical carcinomas
    • Ilvesmäki V, Kahri A, Miettinen P, Voutilainen R. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: High IGF-II expression in functional adrenocortical carcinomas. J Clin Endocrinol Metab 1993; 77: 852-8.
    • (1993) J Clin Endocrinol Metab , vol.77 , pp. 852-858
    • Ilvesmäki, V.1    Kahri, A.2    Miettinen, P.3    Voutilainen, R.4
  • 28
    • 0028298220 scopus 로고
    • Rearrangements at 11p15 locus and overexpression of insulin like growth factor-II gene in sporadic adrenocortical tumors
    • Gicquel C, Bertagna X, Schneid H et al. Rearrangements at 11p15 locus and overexpression of insulin like growth factor-II gene in sporadic adrenocortical tumors. J Clin Endocrinol Metab 1994; 78: 1444-53.
    • (1994) J Clin Endocrinol Metab , vol.78 , pp. 1444-1453
    • Gicquel, C.1    Bertagna, X.2    Schneid, H.3
  • 29
    • 0028059816 scopus 로고
    • Genetic events in the development of Wilms' tumor
    • Coppes M, Haber D, Grundy P. Genetic events in the development of Wilms' tumor. N Engl J Med 1994; 331: 586-90.
    • (1994) N Engl J Med , vol.331 , pp. 586-590
    • Coppes, M.1    Haber, D.2    Grundy, P.3
  • 30
    • 0028587166 scopus 로고
    • The genetics of Wilms' tumor. A case of disrupted development
    • Hastie N. The genetics of Wilms' tumor. A case of disrupted development. Ann Rev Genet 1994; 28: 523-58.
    • (1994) Ann Rev Genet , vol.28 , pp. 523-558
    • Hastie, N.1
  • 31
    • 0029939816 scopus 로고    scopus 로고
    • Somatic overgrowth associated with overexpression of insulin-like growth factor II
    • Morison I, Becroft D, Taniguchi T et al. Somatic overgrowth associated with overexpression of insulin-like growth factor II. Nature Med 1996; 2: 311-6.
    • (1996) Nature Med , vol.2 , pp. 311-316
    • Morison, I.1    Becroft, D.2    Taniguchi, T.3
  • 32
    • 0028800645 scopus 로고
    • Insulin-like growth factors and cancer
    • Le Roith D. Insulin-like growth factors and cancer. Ann Intern Med 1995; 122: 54-9.
    • (1995) Ann Intern Med , vol.122 , pp. 54-59
    • Le Roith, D.1
  • 33
    • 0025967857 scopus 로고
    • Parental imprinting of the mouse insulin-like growth factor II gene
    • De Chiara T, Robertson E, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell 1991; 64: 849-59.
    • (1991) Cell , vol.64 , pp. 849-859
    • De Chiara, T.1    Robertson, E.2    Efstratiadis, A.3
  • 34
    • 0027442239 scopus 로고
    • Tumour-suppressor activity of H19 RNA
    • Hao Y, Crenshaw T, Moulton T et al. Tumour-suppressor activity of H19 RNA. Nature 1993; 365: 764-7.
    • (1993) Nature , vol.365 , pp. 764-767
    • Hao, Y.1    Crenshaw, T.2    Moulton, T.3
  • 35
    • 0028988159 scopus 로고
    • p57 K1P2, a structurally distinct member of the p21CIP2 Cdk inhibitor family, is a candidate tumor suppressor gene
    • Matsuoka S, Edwards M, Bai C et al. p57 K1P2, a structurally distinct member of the p21CIP2 Cdk inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995; 9: 650- 62.
    • (1995) Genes Dev , vol.9 , pp. 650-662
    • Matsuoka, S.1    Edwards, M.2    Bai, C.3
  • 36
    • 0028988158 scopus 로고
    • Cloning of p57 KIP2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution
    • Mong-Hong L, Reynisdottir I, Massagué J. Cloning of p57 KIP2, a cyclin dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995; 9: 639-49.
    • (1995) Genes Dev , vol.9 , pp. 639-649
    • Mong-Hong, L.1    Reynisdottir, I.2    Massagué, J.3
  • 37
    • 0030226250 scopus 로고    scopus 로고
    • p57KIP2 is expressed in Wilm's tumor with LOH of 11p15.5
    • Overall M, Spencer J, Bakker M et al. p57KIP2 is expressed in Wilm's tumor with LOH of 11p15.5. Genes Chrom Cancer 1996; 17: 56-9.
    • (1996) Genes Chrom Cancer , vol.17 , pp. 56-59
    • Overall, M.1    Spencer, J.2    Bakker, M.3
  • 38
    • 0024582517 scopus 로고
    • The Cleveland clinic experience with adrenal cortical carcinoma
    • Bodie B, Novick AC, Pontes JE et al. The Cleveland clinic experience with adrenal cortical carcinoma. J Urol 1989; 141: 257-60.
    • (1989) J Urol , vol.141 , pp. 257-260
    • Bodie, B.1    Novick, A.C.2    Pontes, J.E.3
  • 39
    • 0021044886 scopus 로고
    • Adrenal cortical carcinoma. A continuing challenge
    • Henley DJ, Van Heerden JA, Grant CS et al. Adrenal cortical carcinoma. A continuing challenge. Surgery 1983; 94: 926-31.
    • (1983) Surgery , vol.94 , pp. 926-931
    • Henley, D.J.1    Van Heerden, J.A.2    Grant, C.S.3
  • 40
    • 0027087416 scopus 로고
    • Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French Association of Endocrine Surgery
    • Icard P, Chapuis Y, Andreassian B et al. Adrenocortical carcinoma in surgically treated patients: A retrospective study on 156 cases by the French Association of Endocrine Surgery. Surgery 1992; 112: 972-80.
    • (1992) Surgery , vol.112 , pp. 972-980
    • Icard, P.1    Chapuis, Y.2    Andreassian, B.3
  • 41
    • 0027051533 scopus 로고
    • An eleven-year experience with adrenocortical carcinoma
    • Pommier RF, Brennan MF. An eleven-year experience with adrenocortical carcinoma. Surgery 1992; 112: 963-71.
    • (1992) Surgery , vol.112 , pp. 963-971
    • Pommier, R.F.1    Brennan, M.F.2
  • 42
    • 0021332006 scopus 로고
    • Complete response of metastasized adrenal cortical carcinoma with Op'-DDD
    • Boven E, Vermorken JB, Van Slooten H, Pinedo HM. Complete response of metastasized adrenal cortical carcinoma with Op'-DDD. Cancer 1984; 3: 26-9.
    • (1984) Cancer , vol.3 , pp. 26-29
    • Boven, E.1    Vermorken, J.B.2    Van Slooten, H.3    Pinedo, H.M.4
  • 43
    • 0028208020 scopus 로고
    • Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients
    • Haak HR, Hermans J, Van de Velde CJH et al. Optimal treatment of adrenocortical carcinoma with mitotane: Results in a consecutive series of 96 patients. Br J Cancer 1994; 69: 947-51.
    • (1994) Br J Cancer , vol.69 , pp. 947-951
    • Haak, H.R.1    Hermans, J.2    Van De Velde, C.J.H.3
  • 44
    • 0023633243 scopus 로고
    • The effect of Op'DDD on adrenal steroid replacement therapy requirements
    • Robinson BG, Hales IB, Henniker AJ et al. The effect of Op'DDD on adrenal steroid replacement therapy requirements. Clin Endocrinol 1987; 27: 437-44.
    • (1987) Clin Endocrinol , vol.27 , pp. 437-444
    • Robinson, B.G.1    Hales, I.B.2    Henniker, A.J.3
  • 45
    • 0020558216 scopus 로고
    • Cisplatinum for adrenal cortical carcinoma
    • Chun HG, Yogoda A, Kemeny N. Cisplatinum for adrenal cortical carcinoma. Cancer Treat Rep 1983; 76: 513-4.
    • (1983) Cancer Treat Rep , vol.76 , pp. 513-514
    • Chun, H.G.1    Yogoda, A.2    Kemeny, N.3
  • 46
  • 47
    • 0019306305 scopus 로고
    • Cisplatinum treatment of metaslatic adrenal carcinoma
    • Tattersall MHN, Lander H, Bain B et al. Cisplatinum treatment of metaslatic adrenal carcinoma. Med J Aust 1980; 1: 419-21.
    • (1980) Med J Aust , vol.1 , pp. 419-421
    • Tattersall, M.H.N.1    Lander, H.2    Bain, B.3
  • 48
    • 0027465121 scopus 로고
    • Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: A Southwest Oncology Group Study
    • Bukowski RM, Wolfe M, Levine HS et al. Phase II trial of mitotane and cisplatin in patients with adrenal carcinoma: A Southwest Oncology Group Study. J Clin Oncol 1993; 11: 161-5.
    • (1993) J Clin Oncol , vol.11 , pp. 161-165
    • Bukowski, R.M.1    Wolfe, M.2    Levine, H.S.3
  • 49
    • 0020619434 scopus 로고
    • CAP (Cyclophosphamide, Doxorubicin and Cisplatinum) Regimen in adrenal cortical carcinoma
    • Van Slooten H, Van Oosterom AT. CAP (Cyclophosphamide, Doxorubicin and Cisplatinum) Regimen in adrenal cortical carcinoma. Cancer Treat Rep 1983; 67: 377-9.
    • (1983) Cancer Treat Rep , vol.67 , pp. 377-379
    • Van Slooten, H.1    Van Oosterom, A.T.2
  • 50
    • 0025794205 scopus 로고
    • Fluorouracil, Doxorubicin and Cisplatin as treatment for adrenal cortical carcinoma
    • Schlumberger M, Brugieres L, Gicquel C et al. Fluorouracil, Doxorubicin and Cisplatin as treatment for adrenal cortical carcinoma. Cancer 1991; 67: 2997-3000.
    • (1991) Cancer , vol.67 , pp. 2997-3000
    • Schlumberger, M.1    Brugieres, L.2    Gicquel, C.3
  • 51
    • 0026343069 scopus 로고
    • Eastern Cooperative Oncology Group Study 1879: Mitotane and adriamycin in patients with advanced adrenocortical carcinoma
    • Decker RA, Elson P, Hogan TF et al. for the Eastern Cooperative Oncology Group. Eastern Cooperative Oncology Group Study 1879: Mitotane and adriamycin in patients with advanced adrenocortical carcinoma. Surgery 1991; 110: 1006-13.
    • (1991) Surgery , vol.110 , pp. 1006-1013
    • Decker, R.A.1    Elson, P.2    Hogan, T.F.3
  • 52
    • 0004458012 scopus 로고
    • Chemotherapy with cis-platinum and etoposide (VP16) for patients with advanced adrenal cortical carcinoma (ACC)
    • Proc ASCO
    • Burgess MA, Legha SS, Sellin RV. Chemotherapy with cis-platinum and etoposide (VP16) for patients with advanced adrenal cortical carcinoma (ACC). Proc ASCO, J Clin Oncol 1993; 12: 188.
    • (1993) J Clin Oncol , vol.12 , pp. 188
    • Burgess, M.A.1    Legha, S.S.2    Sellin, R.V.3
  • 53
    • 0025739481 scopus 로고
    • Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (MDR-1/P-Glycoprotein) which is also expressed by adrenocortical carcinoma
    • Bates SE, Shieh CY, Mickley LA et al. Mitotane enhances cytotoxicity of chemotherapy in cell lines expressing a multidrug resistance gene (MDR-1/P-Glycoprotein) which is also expressed by adrenocortical carcinoma. J Clin Endocrinol Metab 1991; 73: 18-29.
    • (1991) J Clin Endocrinol Metab , vol.73 , pp. 18-29
    • Bates, S.E.1    Shieh, C.Y.2    Mickley, L.A.3
  • 54
    • 0027092727 scopus 로고
    • P-glycoprotein expression and multidrug resistance in adrenocortical carcinoma
    • Flynn SD, Murren JR, Kirby WM et al. P-glycoprotein expression and multidrug resistance in adrenocortical carcinoma. Surgery 1992; 112: 981-6.
    • (1992) Surgery , vol.112 , pp. 981-986
    • Flynn, S.D.1    Murren, J.R.2    Kirby, W.M.3
  • 55
    • 0025079187 scopus 로고
    • Suramin in adrenal cancer: Modulation of steroid hormone production. cytotoxicity in vitro, and clinical antitumor effect
    • La Rocca RV, Stein CA, Danesi R et al. Suramin in adrenal cancer: Modulation of steroid hormone production. cytotoxicity in vitro, and clinical antitumor effect. J Clin Endocrinol Metab 1990; 71: 497-504.
    • (1990) J Clin Endocrinol Metab , vol.71 , pp. 497-504
    • La Rocca, R.V.1    Stein, C.A.2    Danesi, R.3
  • 56
    • 0028075055 scopus 로고
    • Suramin in adrenocortical cancer: Limited efficacy and serious toxicity
    • ArIt W, Reincke M, Siekmann L et al. Suramin in adrenocortical cancer: Limited efficacy and serious toxicity. Clin Endocrinol 1994; 41: 299-307.
    • (1994) Clin Endocrinol , vol.41 , pp. 299-307
    • Arit, W.1    Reincke, M.2    Siekmann, L.3
  • 57
    • 0026337882 scopus 로고
    • Suramin and the human adrenocortex: Results of experimental and clinical studies
    • Dorfinger K, Niederle B, Vierhapper H et al. Suramin and the human adrenocortex: Results of experimental and clinical studies. Surgery 1991; 100: 1100-5.
    • (1991) Surgery , vol.100 , pp. 1100-1105
    • Dorfinger, K.1    Niederle, B.2    Vierhapper, H.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.